drugset / Trial / NCT00997542

Allopurinol in Chronic Heart Failure

NCT00997542 ↗

Phase 4 Completed 16 enrolled National Heart and Lung Institute
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to discover whether the inhibition of the xanthine oxidase with allopurinol leads to a reduction of the production of oxygen free radicals in patients with CHF and thereby improves characteristics of oxydative metabolism, peripheral blood flow, immune function and functional status.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule — —

Indications